Patents
More topics under "A61P - Specific therapeutic activity of chemical compounds or medicinal preparations" (2,008,710)
A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
A61P 11 - Drugs for disorders of the respiratory system (87,767)
A61P 13 - Drugs for disorders of the urinary system (56,135)
A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635)
A61P 17 - Drugs for dermatological disorders (106,455)
A61P 19 - Drugs for skeletal disorders (81,981)
A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287)
A61P 23 - Anaesthetics (4,141)
A61P 25 - Drugs for disorders of the nervous system (183,225)
A61P 27 - Drugs for disorders of the senses (53,017)
A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
A61P 3 - Drugs for disorders of the metabolism (129,789)
A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
A61P 33 - Antiparasitic agents (21,787)
A61P 35 - Antineoplastic agents (221,099)
A61P 37 - Drugs for immunological or allergic disorders (117,141)
A61P 39 - General protective or antinoxious agents (19,019)
A61P 41 - Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution (3,707)
A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
A61P 5 - Drugs for disorders of the endocrine system (28,908)
A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
Patents for A61P - Specific therapeutic activity of chemical compounds or medicinal preparations (3,181)
11/2004
11/10/2004CN1545509A Piperidine derivatives useful as modulators of chemokine receptor activity
11/10/2004CN1544088A Immediate release tablet
11/09/2004US6814986 Composition for treating obesity and esthetic treatment process
11/04/2004US20040220209 Novel imidazopyridine compounds with therapeutic effect
11/04/2004US20040220162 Compounds useful in the manufacture of an anti-inflammatory androstane derivative
11/04/2004US20040220157 a 3-oxoandrostrane carbothioic acid compound
11/03/2004EP1337271B1 Combination of gaba agonists and sorbitol dehydrogenase inhibitors
11/03/2004CN1543464A Novel imidazopyridine compounds with therapeutic effect
11/03/2004CN1173703C Pharmaceutical composition
11/03/2004CN1173692C Cosmetic composition and method for reducing skin aging procedure
11/02/2004US6812219 Methods and compositions for treating flaviviruses and pestiviruses
10/2004
10/28/2004US20040214843 Such as spiro(cyclohexane-1-4'-(3',4'-dihydro)quinazolin)-2'(1'H)-one for treatment of T-cell-related diseases, autoimmune diseases, osteoarthritis, multiple sclerosis, osteoporosis, asthma and cancer
10/28/2004US20040214841 Quinazoline derivatives for treatment of tumours
10/28/2004US20040214821 Benzimidazole compounds for modulating IgE and inhibiting cellular proliferation
10/28/2004US20040214814 Pyrazole compounds useful as protein kinase inhibitors
10/28/2004US20040214793 In aitu applying to bone joints
10/27/2004EP1471054A1 Amino alcohol derivative or phosphonic acid derivative and medicinal composition containing these
10/27/2004CN1541225A Humanized antibodies that recognize beta amyloid peptide
10/21/2004WO2004089940A1 Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them
10/21/2004US20040209938 Novel 1,3-dihydro-2H-indol-2one derivatives, process for preparing them and pharmaceutical compositions containing them
10/21/2004US20040209922 Pyridine matrix metalloproteinase inhibitors
10/21/2004CA2522023A1 Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them
10/20/2004EP1468686A2 S-methyl-dihydro-ziprasidone for treatment of psychiatric disorders
10/20/2004EP1467731A1 3-(imidazolyl)-2-alkoxypropanoic acids as tafia inhibitors
10/20/2004EP1230236B1 Compound with growth hormone releasing properties
10/20/2004EP1206473B1 Isomeric fused pyrrolocarbazoles and isoindolones
10/20/2004EP1149074B1 Acetylenic sulfonamide thiol tace inhibitors
10/20/2004EP1140941B1 Nitrogen containing heterobicycles as factor xa inhibitors
10/13/2004EP1465864A1 Inhibitors of factor xa and other serine proteases involved in the coagulation cascade
10/13/2004EP1257584B1 Humanized antibodies that sequester amyloid beta peptide
10/13/2004EP1165069B1 Antitumour synergistic composition
10/13/2004CN1537112A Pyrimidine compound
10/13/2004CN1537101A Pyridine matrix metalloproteinase inhibitors
10/13/2004CN1537008A Pharmaceutical combination comprising either (S)-20ethoxy-3-[4-(2-{4-methane sulfonyl oxyphenyl}ethoxy)phenyl] propanoic acid
10/13/2004CN1537007A 2 methyl-thieno-benzodiazepine lyophilizde formulation
10/13/2004CN1170817C 前列腺素e类似物 E prostaglandin analogs
10/07/2004US20040198787 Efficient process for the preparation of a factor Xa inhibitor
10/07/2004US20040198782 treatment of neoplastic diseases that respond to inhibition of the vascular endothelial growth factor receptor tyrosine kinase activity; tumors, retinopathy, macular degeneration
10/06/2004CN1535155A Pharmaceutical combination comprising either (S)-2-ethyxy-3 [4-(2-{4-methane sulfonyl oxyphenyl} ethoxy) phenyl] propanoic acid or 3-{4-[2-(4-tert-butoxy carbonylamino phenyl) ethoxy] phenyl}
10/06/2004CN1535144A Pharmaceutical combination comprising either (S)-2-ethoxy-3-[4-(2-{4-methane sulfonyl oxyphenyl} ethoxy) phenyl] propanoic aicd or 3-{4-[2-(4-tert-butoxy carbonyl aminophenyl) ethyoxy] phenyl}
10/05/2004US6800660 Bis(thio-hydrazide amide) compounds; anticancer agents
09/2004
09/29/2004EP1462442A1 Crystals of bicalutamide and process for their production
09/29/2004EP0878199B1 Natural tea comprising alder and mountain ash extracts for treating the effects of alcoholic drinks
09/29/2004CN1533387A 1-phenysulfonyl-1,3-dihydro-2H-indole-2-one derivatives, their preparation and their therapeutic use
09/23/2004US20040186133 preferably antagonists used in the therapeutic and/or preventive treatment of disfunctions of the heart, kidney, respiratory system, central nervous system
09/23/2004US20040185122 Selective COX-2 inhibition from edible plant extracts
09/23/2004US20040185098 Making oral dosage form by forming granules comprising oxycodone hydrochloride, alkyl cellulose and polymethacrylate, and drying said granules
09/22/2004EP1458690A1 5,6-diaryl-pyrazine-2-amide derivatives as cb1 antagonists
09/22/2004EP1458689A1 Aryloxyphenyl and arylsulfanylphenyl derivatives
09/22/2004EP1458376A1 Darifenacin for use in the treatment of urgency induced by overactive bladder
09/22/2004EP1187629B1 Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide
09/21/2004US6794402 Bicyclic cyclohexylamines and their use as NMDA receptor antagonists
09/16/2004US20040180964 anti-obestic activity; Neuropeptide Y antagonist
09/16/2004US20040180878 Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use
09/15/2004EP1457490A1 5-membered N-heterocyclic compounds with hypoglycemic and hypolipidemic activity
09/15/2004EP1455786A1 Use of a compound in the treatment of sleep disorders and the like in providing refreshedness on waking and a method for the treatment of grogginess therewith
09/15/2004EP1246638B1 Use of exendins and agonists thereof for the treatment of hypertriglyceridemia
09/15/2004EP1173210B1 Contraceptive compositions containing antiprogestinic and progestinic
09/15/2004CN1166668C Method for preparing substituted [1,4] diazepino (6,7,1-hi) indol-4-ones
09/14/2004US6790850 Thiazolo(4,5-d)pyrimidine compounds
09/10/2004WO2004075988A2 Methods of immunomodulation in animals
09/10/2004WO2003061652A8 3-(imidazolyl)-2-alkoxypropanoic acids as tafia inhibitors
09/09/2004US20040176462 NPY Y5 antagonist
09/09/2004US20040176357 Stable, amorphous , lyophilized, parenteral injections comprising olanzapine, solubilizer and stabilizer; bipolar, psychological and neurodegenerative disorders; anxiolytic agents;schizophrenia
09/09/2004US20040176324 Derivatives of 4,7-ethanothiopyrano[3,4-c]pyrrole-1,3-(2H)-dione, 4,7-epoxy-1H-isoindole-1,3(2H)-dione, and/or 4,7-ethano-1H-pyrrolo[3,4-c]pyridine-1,3(2H)-dione derivatives; autoimmune diseases; anticarcinogenic agents
09/08/2004EP1165505B1 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
09/08/2004CN1527816A New indole derivatives with 5-HT6 receptor affinity
09/08/2004CN1165310C Drug-(combinations comprising (E)-7-[4-(4-fluorophenyl)-6-isopropyl-2- [methyl(methylsulfonyl)amino]pyrimidin-5-yl](3R,5S)-3,5-dihydroxyhept-6- enoic acid and an inhibitor,inducer or substrate of P450
09/08/2004CN1165307C Controlled release oxycodone compositions
09/08/2004CN1165299C Composition for treatment of psoriasis
09/08/2004CN1165289C Veterinary formulation for administration of a water-insoluble drug to a target animal through a water distribution system
09/07/2004US6787549 For therapy of inflammatory bowel disease, ulcerative colitis, pyoderma gangrenosum, crohn's disease, irritable bowel syndrome, spastic dystonia, chronic pain, acute pain, celiac sprue, pouchitis, vasoconstriction, anxiety, panic disorder
09/07/2004US6787535 Indole derivatives with 5HT6 receptor affinity
09/02/2004WO2004074262A1 Hiv replication inhibiting pyrimidines and triazines
09/02/2004WO2004074261A1 Hiv replication inhibiting pyrimidines and triazines
09/02/2004WO2004073736A1 Attenuated strains of vibrio cholerae and lyophilised vaccines containing same
09/02/2004WO2003099786A3 Aromatic sulfones and their medical use
09/02/2004US20040171848 Fluoropyrrolidines as dipeptidyl peptidase inhibitors
09/01/2004EP1450834A1 Allium sativum bulb absolutes and therapeutic or cosmetic uses
09/01/2004EP1292594B1 Quinazoline derivatives for the treatment of tumours
09/01/2004EP1165528B1 Novel morpholine derivatives, method for the production thereof and pharmaceutical preparations containing said derivatives
08/2004
08/31/2004US6784198 Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents
08/26/2004US20040167141 Anticancer agents; antidiabetic agents; Alzheimer's disease
08/25/2004EP1448566A2 Chemokine receptor antagonists and methods of use thereof
08/25/2004EP1448524A1 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5)
08/25/2004EP1448523A1 Heterocyclic compounds and methods of use
08/25/2004EP1448201A2 Use of n-(indolcarbonyl-)piperazine derivatives
08/25/2004EP1448182A1 Pharmaceutical compositions and methods for administering ep 2 receptor selective agonists
08/24/2004US6780972 Reacting an acid addition salt of a basic starting peptide in the presence of a diluent in a mixed bed ion exchanger; forming a free peptide; and then forming the desired acid addition salt of the peptide
08/24/2004US6780879 As antitumor agent
08/18/2004EP1446131A1 Use of specific dose of fondaparinux sodium for the treatment of acs
08/18/2004EP1446123A1 Rosuvastatin in pre demented states
08/18/2004EP1446122A1 Use of flibanserin in the treatment of sexual disorders
08/17/2004US6777543 13-methyl erythromycin derivatives
08/17/2004US6777406 Substituted pyrroloquinolines and pyridoquinolines as serotinin agonists and antagonists
08/12/2004WO2004045718A3 Treatment of cognitive dysfunctions'
08/12/2004US20040157927 Pharmaceutical combination comprising either (s)-2-ethoxy-3-[4-(2-{4-methane sulfonyl oxyphenyl} ethoxy) phenyl] propanoic acid or 3-{-4-[2-(4-tert-butoxy carbonyl aminophenyl) ethoxy] phenyl}-(s)-2-ethoxy propanoic acid and a sulonylurea
08/12/2004US20040157893 Pyrazole compounds useful as protein kinase inhibitors
08/12/2004US20040157886 Brain disorders; central nervous system disorders; viricides
08/11/2004EP1443945A1 Use of a mixture of sodium hyaluronate and chondroitin sulfate for the treatment of osteoarthritis
1 ... 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 ... 32